ロード中...
FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes
AIMS/HYPOTHESIS: Fibroblast growth factor 21 (FGF21) is considered to be a promising therapeutic candidate for the treatment of type 2 diabetes. However, as FGF21 levels are elevated in obese and diabetic conditions we aimed to test if exogenous FGF21 is sufficient to prevent diabetes and beta cell...
保存先:
| 出版年: | Diabetologia |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6448882/ https://ncbi.nlm.nih.gov/pubmed/28770320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-017-4389-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|